Dataset opportunity
Medistri — 医疗影像数据集机会
Medistri 持有的中等规模医疗影像数据集，可用于诊断 AI 和计算机视觉。
Score
65.7
Score (0–100) blends weighted dimensions — dataset rarity, training value, buyer demand, evidence strength and right-to-license. 70+ is deal-ready. See the scored dimensions below for the breakdown.Confidence
49%
Action
收购
The recommended deal structure for this dataset: Acquire (full buyout), License (paid usage rights), Data Sharing Agreement (controlled access, no transfer of ownership), Partnership (co-development) or Annotation Program (labeling). Chosen from data ownership, licensing complexity and accessibility.Market size (indicative estimate)
全球诊断 AI 市场 = 2025 年为 20 亿美元，复合年增长率为 21.7%。
Lineage
How this lead was derived
The signal-first chain, end to end: recent external signals → qualified niche → resolved data-holder → site verification → scored opportunity. Every lead is explainable.
Concrete evidence this company actively cares about data — why it's ripe for the deal room.
- ✨Signal
Medistri 实验室技术基础设施和验证服务
source ↗
Profile
Dataset profile
Type
医疗影像数据集
Modality
图像
Sector
healthcare
Volume
中等
Freshness
定期
Rarity
高（专有）
Accessibility
受限
Legal
混合所有权 — 许可权待明确 · PII/受监管
Buyer persona
医疗 AI 和诊断影像公司
Medistri 持有一个专门的医疗影像数据集，属于图像模态，源自其核心医疗服务。数据由工业记录、`medical_records` 和监管文件支持，提供了一个高度结构化且可追溯的集合，非常适合训练和验证诊断 AI 模型，用于异常检测和医疗设备测试中的质量控制等任务。
该数据集位于快速增长的诊断 AI 市场内，该市场在 2025 年的估值为20 亿美元，预计将以21.7% 的复合年增长率扩张。[2, 4] 虽然由于ISO 13485 等严格的监管标准和客户保密协议，访问权限需要协商，但这种合规级别数据的稀有性和高保真度为 AI 开发人员提供了显著的竞争优势，证明了访问它所需的尽职调查是值得的。⚠ 尽职调查（有价值的数据，可协商访问）：数据受严格的医疗和制药监管标准（ISO 13485、FDA）约束；与 MedTech/Pharma 客户就特定测试结果签订保密协议；技术数据可能被隔离在工业控制系统和 LIMS（实验室信息管理系统）中 · corporate: independent。
Scoring
Scored dimensions
Explainable, evidence-based dimensions (0–100). The radar shows the investment axes.
这些证据共同证明 Medistri 拥有来自医疗设备灭菌测试和化学分析的图像和日志的专有数据集。这些数据对于开发自动化诊断 AI 以用于实验室和质量控制环境的 AI 买家至关重要，这是快速增长的诊断 AI 市场的一个关键细分市场。随着该市场预计到 2025 年将达到 20 亿美元，这个稀有的数据集提供了训练模型用于高风险工业应用的地面真实性，提供了显著的竞争优势。
See dimension details ↓- Data Orientation39
1 数据需求信号（1 种类型）
How actively the company invests in data, measured by its data-appetite signals (hires, products, APIs…). - Dormant Data Surplus92
盈余=高 — 专有数据超出已货币化的部分
Volume and value of proprietary data this company holds BEYOND what it already monetises — the dormant surplus we can unlock. A company can sell some insights AND still sit on a far larger dormant asset. - ICP Audit100
✓ 良好目标 — Medistri 是一个良好目标，因为其核心业务是为医疗行业提供合同灭菌和实验室服务，这些服务会产生有价值的运营数据作为副产品，而没有任何出售的迹象。问题：最初的提示提到了“医疗影像数据集机会”，但该公司的实际业务是合同灭菌和实验室服务。数据生成
- Deep Qualification90
⚠ 需要审查 — Medistri 是 MedTech 行业的合同服务组织，持有有价值的设备性能和验证数据。然而，这些数据归其客户所有，并受保密协议约束，使得第三方货币化极不可能。[数据归公司客户所有；许可受限；数据集类型与实际活动不符：标签“医疗影像数据集”具有误导性。Medistri 的服务涉及医疗设备的灭菌和实验室测试，而不是临床影像。生成的任何图像都将用于工业质量控制设备或包装（例如，染料渗透测试、显微镜检查），而不是诊断医学图像（X 射线、MRI）。[2, 6]]
- Dataset Specificity90
占主导地位的“medical_records”，行业 healthcare，3 种特定类型
How sharply the data targets a specific, hard-to-substitute domain or task. Niche, well-defined data scores higher than generic. - Dataset Rarity82
专有领域数据
How scarce and proprietary the data is. Unique domain data scores high; openly available data lowers it. - Dataset Volume52
3 条证据命中
Apparent scale of the data, inferred from the number of evidence hits and any explicit volume mentions. - Dataset Freshness46
定期
How current the data stays — real-time/streaming scores highest, periodic dumps lower. - Training Value84
适用于诊断 AI
How useful the data is for the target AI use-case — its fit for model training or fine-tuning. - Buyer Demand90
买家需求异常高，这得益于争夺诊断 AI 市场份额的竞争，该市场预计将以 21.7% 的复合年增长率增长。[2, 4]
How strongly AI builders and companies are likely to want this data, based on market signals. - Legal Accessibility0
PII/受监管
How legally easy the data is to obtain and use — open/API access scores high; PII or regulated data scores low. - Acquisition Feasibility0
中等难度，独立
How realistic it is to actually obtain the data, given access difficulty and the holder's corporate structure. - Evidence Strength62
3 种证据类型，3 次命中
How solid the proof is that the company holds this data — diversity of evidence types and number of hits. - Right to License36
所有权=混合，许可=权利不明确
Whether the company can legally license the data out — based on ownership and licensing complexity. - Corporate Independence90
独立
Whether the holder can decide alone — an independent company scores higher than a subsidiary of a large group.
Evidence
Dataset evidence & lineage
What the typed evidence proves the company holds — reframed for clarity and set against the market.
Industrial data
该公司持有来自工业灭菌过程的详细时间序列数据，这对于开发医疗制造的预测性维护和过程优化 AI 非常有价值。
Medical records / imaging
这是一系列专有的生物负荷测试和化学分析图像，对于训练计算机视觉模型以自动化医疗设备的质量控制和安全检查至关重要。
Regulatory records
该数据集包括关于灭菌验证和环境监测的专有文本记录，为构建符合严格监管和合规标准的 AI 系统提供了关键背景。
Marketplace
Dataset details
Detailed schema & sample available on access request.
Want this data?
Request access — we broker a secure deal room. Operator-reviewed, no automatic sharing.
This listing was generated automatically from public signals. It is not verified, and we are not affiliated with this company.
Coverage
Scanned sources
Deliverable
Premium dataset report
Medistri Medical Imaging — a Moderate medical imaging dataset (Image modality) in the healthcare domain. Primary AI use-case: Diagnostic AI. Market signal: Global Artificial Intelligence in Diagnostics market = $2.0 billion in 2025, CAGR 21.7% (source: Grand View Research). Investment score 65.7/100 (confidence 0.49). Recommended action: Acquire.
From the marketplace
Explore live data opportunities
Palibex — 移动遥测数据集机会
View opportunity →医疗保健Bellaseno — 医疗影像数据集机会
View opportunity →工业Bauwatch — 工业传感器数据集机会
View opportunity →